Investing.com - Rockwell Medical (NASDAQ: RMTI) reported third quarter EPS of $0.0900, $0.08 better than the analyst estimate of $0.0100. Revenue for the quarter came in at $28.3M versus the consensus estimate of $26.5M.
Guidance
Rockwell Medical sees FY 2024 revenue of $98.0000M-$101.0000M versus the analyst consensus of $100.2000M.
Rockwell Medical's stock price closed at $4.65. It is up 81.6400% in the last 3 months and up 136.0400% in the last 12 months.
Rockwell Medical saw positive EPS revisions and negative EPS revisions in the last 90 days. See Rockwell Medical's stock price’s past reactions to earnings here.
According to InvestingPro, Rockwell Medical's Financial Health score is "great performance".
Check out Rockwell Medical's recent earnings performance, and Rockwell Medical's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar